RISING PHARMACEUTICALS recalls
Every recall we track for RISING PHARMACEUTICALS — 3 in all, from 2021–2023 — plus the complaints and injury reports the public filed about them.
Recalls per year, by danger level
3 recalls since 2017.
All FDA recall records for RISING PHARMACEUTICALS since 2017, counted by recall date (one bar per calendar year; 2026 is partial). Danger level is GovInfoNow’s plain-language rating; “not yet rated” records are still being written up.
| Year | Stop using now | Use caution | Lower risk | Not yet rated | Total |
|---|---|---|---|---|---|
| 2017 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 1 | 0 | 1 |
| 2022 | 0 | 0 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 0 | 0 | 1 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2026 (to date) | 0 | 0 | 0 | 0 | 0 |
What to do if you have a recalled RISING PHARMACEUTICALS product
- Match the NDC and lot number on your bottle or box to the recall.
- Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first.
- Report side effects to FDA MedWatch.
All RISING PHARMACEUTICALS recalls
3 shown- Use cautionDrug
RISING PHARMACEUTICALS recalls Warfarin Sodium Tablets, USP 1 mg, 100-count bottle, Rx Only, Distributed by: Rising Health, LLC, Saddle Brook, NJ
Rising Pharmaceuticals recalls 100-count Warfarin Sodium tablets (NDC 57237-119-01) due to impurities that could cause serious injury. Affected batches expire April 2023.
Rising PharmaceuticalsFeb 15, 2023 - Lower riskDrug
RISING PHARMACEUTICALS recalls Methylphenidate Hydrochloride Chewable Tablets, 2.5 mg, 100-count bottle, Rx Only, Manufactured for: Rising
Rising Pharmaceuticals recalls 2.5 mg chewable methylphenidate tablets due to size variation in some tablets. This may affect safety and requires verification of product details.
Rising PharmaceuticalsFeb 7, 2022 - Lower riskDrug
RISING PHARMACEUTICALS recalls Meclizine HCl Tablets, 25 mg, packaged in 100-count HDPE bottle, Distributed by: Rising Pharma Holdings, Inc. East
Rising Pharmaceuticals recalls 25mg Meclizine HCl tablets with incorrect labeling instructions. Consumers should check product details and contact the company for guidance.
Rising PharmaceuticalsSep 2, 2021
RISING PHARMACEUTICALS recall questions
How many recalls has RISING PHARMACEUTICALS had?
3 recalls from RISING PHARMACEUTICALS are on record with U.S. safety agencies, from 2021–2023.
What is the most recent RISING PHARMACEUTICALS recall?
RISING PHARMACEUTICALS recalls Warfarin Sodium Tablets, USP 1 mg, 100-count bottle, Rx Only, Distributed by: Rising Health, LLC, Saddle Brook, NJ, dated Feb 15, 2023. Every RISING PHARMACEUTICALS recall is listed on this page, newest first.
What should I do if I have a recalled RISING PHARMACEUTICALS product?
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
How do I get alerts for new RISING PHARMACEUTICALS recalls?
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.